There may be many opportunities for investors in the coming days. In fact, three companies – Balaji Solutions, Go Digit General Insurance and Concorde Biotech – have submitted preliminary documents to SEBI.
Coming together IPO of 3 companies, new opportunity for investors to earn
The first half of 2022 has not been very favorable for investors betting on initial public offerings (IPOs). However, there may be many opportunities for investors in the coming days. In fact, three companies – Balaji Solutions, Go Digit General Insurance and Concorde Biotech – have submitted preliminary documents to SEBI. Let’s know the details.
Best IPO to invest in 2022 India
IT hardware and mobile accessories company Balaji Solutions has also filed preliminary documents with SEBI. According to the document, new shares of up to Rs 120 crore will be issued in the IPO. The promoters and promoter group of the company will bring an offer for sale (OFS) of 75 lakh equity shares.
Under the OFS, Rajendra Seksaria and Rajendra Seksaria will sell the shares of the HUF. The offer also includes reservation for membership by eligible employees. Before the IPO of the company, Rs. Can consider placement up to 24 crores. If the planning is completed, the size of the new IPO will be reduced.
Go Digit General Insurance
Canada’s Fairfax Group backed Go Digit General Insurance Limited has also submitted preliminary documents to SEBI. IPO Rs. New shares worth Rs 1,250 crore will be issued. In addition, the promoters and existing shareholders will bring an offer for sale (OFS) of 10,94,45,561 equity shares. Go Digit Infoworks Services Private Limited will sell 10,94,34,783 equity shares under OFS.
Also, the company’s pre-IPO placement is Rs. Can bring up to 250 crores. Let us tell you that cricketer Virat Kohli and his wife Anushka Sharma are among the investors of Go Digit General Insurance.
Rare Enterprises backed Concorde Biotech has filed draft documents with SEBI. The IPO will be purely in the form of Offer for Sale (OFS). The Offer for Sale (OFS) of 2,09,25,652 equity shares will be initiated by Helix Investment Holdings Pte Ltd, backed by private equity firm Quadria Capital. It is proposed to reserve shares for eligible employees under the IPO.
Concorde is one of the leading manufacturers of Yeast-based Bio Pharma API. It has three units in Gujarat. The company is backed by Quadria Capital Fund and Rare Enterprises, which was founded by billionaire investor late Rakesh Jhunjhunwala along with his wife Rekha.